In addition to the described deleterious effects of IFNγ on astrocyte mitochondrial dysfunction, there is still much to learn about IFNγ signaling in astrocytes during the chronic stages of MS and EAE, where IFNγ has a more protective role [13,14]. The gene discussed is IFNG; the disease is myeloid sarcoma.